These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 47361)

  • 1. In vitro response of mouse spleen cells to the solid phase immunogen DNP-O-Bio-Gel.
    Trump GN
    J Immunol; 1975 Feb; 114(2 Pt 1):682-7. PubMed ID: 47361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogen structure and cell selection. I. Cellular requirements for the in vitro response to moderately haptenated forms of the solid-phase immunogen DNP-O-Bio-Gel-P.
    Trump GN
    J Immunol; 1976 Aug; 117(2):419-22. PubMed ID: 1084896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular basis for a hapten-specific state of tolerance induced in vitro.
    Kim YT; Mazer T; Weksler ME; Siskind GW
    J Immunol; 1978 Oct; 121(4):1315-20. PubMed ID: 81228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell co-operation and hapten--carrier complexes.
    Snippe H; Kamp E
    Immunology; 1975 Oct; 29(4):675-85. PubMed ID: 52618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of hapten-specific antibody-forming cell precursors in microcultures.
    Stocker JW
    Immunology; 1976 Feb; 30(2):181-7. PubMed ID: 770314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody formation in the mouse induced by hapten-carrier complexes.
    Snippe H; Graven WG; Willems PJ
    Immunology; 1975 May; 28(5):885-95. PubMed ID: 48501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of immune response in allogeneic mixed spleen cell cultures. I. Influence of I-region on the generation of suppressor cells.
    Kim YT; Schwartz A; Moody C; Siskind GW; Weksler ME
    J Immunol; 1980 Oct; 125(4):1724-9. PubMed ID: 6447730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor.
    Kishimoto T; Ishizaka K
    J Immunol; 1975 Feb; 114(2 Pt 1):585-91. PubMed ID: 1079034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro immunogenicity, tolerogenicity and mitogenicity of dinitrophenyl-levan conjugates with varying epitope density.
    Desaymard C; Ivanyi L
    Immunology; 1976 May; 30(5):647-53. PubMed ID: 58831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hypersensitivity in the mouse induced by hapten-carrier complexes.
    Snippe H; Willems PJ; Graven WG; Kamp E
    Immunology; 1975 May; 28(5):897-907. PubMed ID: 48502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potentiality of antibody-producing cells. I Bispecific cell occurrence in double stimulated cultures of syngeneic or allogeneic spleen cells of the mouse.
    Couderc J; Bleux C; Birrien JL; Liacopoulos P
    Immunology; 1975 Oct; 29(4):653-64. PubMed ID: 1102444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation of antigen-specific lymphocytes. II. Enrichment of hapten-specific antibody-forming cell precursors.
    Haas W
    J Exp Med; 1975 May; 141(5):1015-29. PubMed ID: 165257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody formation against 2,4-dinitrophenyl-hapten at the cellular level. Hemolytic plaque-in-gel assay for lymphoid cells producing anti-2,4-dinitrophenyl-hapten antibody.
    Yamada H; Yamada A
    J Immunol; 1969 Aug; 103(2):357-63. PubMed ID: 4979592
    [No Abstract]   [Full Text] [Related]  

  • 14. The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cells.
    Cowdery JS; Laskin CA; Steinberg AD
    J Immunol; 1982 Apr; 128(4):1571-6. PubMed ID: 6174607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on tolerance induction of the mode of attachment of the hapten the carrier.
    Paley RS; Leskowitz S; Borel Y
    J Immunol; 1975 Nov; 115(5):1409-13. PubMed ID: 1100732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potentiality of antibody-producing cells. II. Evidence for two antibody molecules of different specificities secreted by micromanipulated bispecific mouse spleen cells.
    Couderg J; Bleux C; Liacopoulos P
    Immunology; 1975 Oct; 29(4):665-74. PubMed ID: 52617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates.
    Lee WY; Sehon AH
    J Immunol; 1976 Jun; 116(6):1711-8. PubMed ID: 58048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro immune response to the 2,4,6-trinitrophenyl determinant in aged C57BL/6J mice:changes in the humoral immune response to, avidity for the TNP determinant and responsiveness to LPS effect with aging.
    Kishimoto S; Takahama T; Mizumachi H
    J Immunol; 1976 Feb; 116(2):294-300. PubMed ID: 55434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of hapten-reactive thymus-derived helper lymphocytes on the tolerance induction in hapten-specific precursors of antibody-forming cells.
    Hamaoka T; Inada T; Yamashita U; Kitagawa M
    J Immunol; 1975 Jun; 114(6):1771-8. PubMed ID: 47879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hapten-specific responses to contact sensitizers. Use of fluorodinitrobenzene to elicit migration inhibition and macrophage agglutination factors from lymph node cells of contact-sensitive guinea-pigs.
    Godfrey HP
    Immunology; 1976 May; 30(5):685-94. PubMed ID: 58832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.